<DOC>
	<DOCNO>NCT00805909</DOCNO>
	<brief_summary>The purpose study determine safety tolerability NI-0401 whether NI-0401 reverse BpACR .</brief_summary>
	<brief_title>NI-0401 Patients With Acute Renal Allograft Rejection</brief_title>
	<detailed_description />
	<criteria>Main inclusion Criteria : evidence cellular rejection renal biopsy accord Bannff 97 criterion rise Serum Creatinine concentration &gt; 20 % compare baseline value Main previous therapy antiCD3 mAB ( OKT3 ) antilymphocytes polyclonal antibody ( ATG , Atgam ) patient cardiac insufficiency fluid overload severe HLA sensitization ( &gt; 50 % panel reactive antibody prior transplantation ) define concomitant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>